Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Dr Reddy's Laboratories Ltd

+ Add to Watchlist


3,527.95 INR 58.70 1.64%

As of 07:05:46 ET on 05/28/2015.

Snapshot for Dr Reddy's Laboratories Ltd (DRRD)

Open: 3,586.80 Day's Range: 3,500.50 - 3,615.50 Volume: 302,950
Previous Close: 3,586.65 52wk Range: 2,291.15 - 3,808.75 1-Yr Rtn: +51.02%

Stock Chart for DRRD

No chart data available.
  • DRRD:IN 3,527.95
  • 1D
  • 1M
  • 1Y
Interactive DRRD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRRD

Current P/E Ratio (ttm) 27.2462
Estimated P/E(03/2016) 23.6903
Relative P/E vs. SENSEX 1.2561
Earnings Per Share (INR) (ttm) 130.2200
Est. EPS (INR) (03/2016) 149.7660
Est. PEG Ratio 1.4199
Market Cap (M INR) 604,256.58
Shares Outstanding (M) 170.31
30 Day Average Volume 373,924
Price/Book (mrq) 5.4006
Price/Sale (ttm) 4.0547
Dividend Indicated Gross Yield 0.56%
Cash Dividend (INR) 20.0000
Dividend Ex-Date
5 Year Dividend Growth 23.56%
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRRD

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for DRRD

Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.

G V PrasadCo-Chair/CEO/Mng DirSaumen ChakrabortyPresident/CFO
Abhijit MukherjeeChief Operating OfficerSripada ChandrasekharPres & Global Head:Human Resources
More Company Profile & Key Executives for DRRD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil